StevenDanielKleinMDPhD

Summary

• Dr. Steven Daniel Klein is a distinguished physician and researcher specializing in medical genetics and addiction medicine. Currently, he is pursuing a fellowship in Addiction Medicine at Caron Treatment Center and Tower Health, with a focused career aim of uniting his diverse passions to treat adolescents struggling with substance use disorders.
  
  Dr. Klein completed his combined residency and fellowship in Pediatrics and Medical Genetics at the Children’s Hospital of Philadelphia (CHOP) from 2019 to 2023. He had previously trained at UCLA-Caltech, where he earned his MD in 2019 as part of the prestigious Medical Scientist Training Program (MSTP), and a PhD in Human Genetics from UCLA in 2017. His foundational education was completed at the University of Rochester, where he obtained his BS in Molecular Genetics, complemented by a minor in American Sign Language.
  
  His research career spans several notable projects. Dr. Klein conducted postdoctoral research focusing on the molecular basis of Beckwith-Wiedemann Syndrome (BWS). Prior to this, he worked with Dr. Julian Martinez-Agosto at UCLA, contributing to significant discoveries related to Autism and overgrowth disorders. His current research interests are centered on understanding the role of methylation in the heritability of addiction through stress responses, aiming to elucidate the underlying mechanisms of substance use disorders.
  
  Dr. Klein holds board certifications or eligibility from the American Board of Pediatrics, and the American Board of Medical Genetics and Genomics. He is licensed to practice medicine in Pennsylvania and holds a DEA registration.
  
  In addition to his clinical and research roles, Dr. Klein is actively involved in professional and community service. He serves as a Board Member and Membership Committee Chair for the International Doctors of Alcoholics Anonymous (IDAA), where he leverages his personal recovery experience to support his colleagues.